indole has been researched along with Hypertension, Pulmonary in 1 studies
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azaindole-1 treatment resulted in a decreased immunoreactivity for phospho-myosin phosphatase target subunit 1 and proliferating cell nuclear antigen in pulmonary vessels of MCT-injected rats, suggesting an impaired ROCK activity and reduced proliferating cells." | 5.36 | Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension. ( Dahal, BK; Ghofrani, HA; Grimminger, F; Kast, R; Kosanovic, D; Lai, YJ; Pamarthi, PK; Schermuly, RT; Schirok, H; Seeger, W; Stasch, JP; Sydykov, A; Weissmann, N, 2010) |
| "Azaindole-1 treatment resulted in a decreased immunoreactivity for phospho-myosin phosphatase target subunit 1 and proliferating cell nuclear antigen in pulmonary vessels of MCT-injected rats, suggesting an impaired ROCK activity and reduced proliferating cells." | 1.36 | Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension. ( Dahal, BK; Ghofrani, HA; Grimminger, F; Kast, R; Kosanovic, D; Lai, YJ; Pamarthi, PK; Schermuly, RT; Schirok, H; Seeger, W; Stasch, JP; Sydykov, A; Weissmann, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahal, BK | 1 |
| Kosanovic, D | 1 |
| Pamarthi, PK | 1 |
| Sydykov, A | 1 |
| Lai, YJ | 1 |
| Kast, R | 1 |
| Schirok, H | 1 |
| Stasch, JP | 1 |
| Ghofrani, HA | 1 |
| Weissmann, N | 1 |
| Grimminger, F | 1 |
| Seeger, W | 1 |
| Schermuly, RT | 1 |
1 other study available for indole and Hypertension, Pulmonary
| Article | Year |
|---|---|
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension.
Topics: Animals; Azabicyclo Compounds; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Hemody | 2010 |